Enterprise reports phase 2 cystic fibrosis win, succeeding where Big Pharma stumbled

Summary: A small company named Enterprise Therapeutics just had a huge win in treating cystic fibrosis (CF). They tested a new inhaled medicine called ETD001. This drug is made to help the 10% of CF patients who cannot use current popular treatments.

In a 28-day study, patients who breathed in this new medicine saw a 3.4% improvement in their lung function. What makes this so amazing? Giant drug companies like Vertex, Novartis, and AstraZeneca tried to make this exact type of drug before, but they all failed and gave up. Enterprise succeeded because they designed their drug to stay in the lungs much longer. They actually figured this out by testing it on sheep first! Now, they are planning longer trials to see how well it works over time.

For more details, see rssapp-fiercebiotech-com at fiercebiotech.com/biotech/enterprise-reports-phase-2-cystic-fibrosis-win-succeeding-where-big-pharma-stumbled (opens in new tab)